Translator Disclaimer
1 December 2006 Molecular Analysis of Brazilian Infectious Bronchitis Field Isolates by Reverse Transcription–Polymerase Chain Reaction, Restriction Fragment Length Polymorphism, and Partial Sequencing of the N Gene
Author Affiliations +
Abstract

Molecular analysis of 15 Brazilian infectious bronchitis virus (IBV) isolates, obtained from clinical outbreaks of the disease in chickens (broilers or layers) in the state of Minas Gerais (Brazil) between 1972 and 1989, is reported. Using the N protein gene as target, IBVs were analyzed by reverse transcription–polymerase chain reaction/restriction fragment length polymorphism (RT-PCR/RFLP) with the restriction enzymes AvaII, HphI, Sau96I, and Tsp509I and cDNA sequencing. Results obtained from those isolates were compared to 19 sequences available in GenBank. N gene RFLP profiles, cDNA sequences, and predicted amino acid composition were used for the construction of dendrograms. Brazilian isolates were grouped into one distinct group. Identity of predicted N protein amino acid composition varied from 45% (between isolates G and 208) up to 99% (PM1 and PM2), and, when compared to the other IBVs, the amino acid identity was from 42% (Q3/88 and G) up to 97% (D41 and PM1). The great genetic diversity was shown to occur before the official use of vaccination in Brazil and has remained thereafter.

Infectious bronchitis (IB) is a global widespread highly contagious and economically important viral disease of chickens (4,5) caused by a coronavirus (infectious bronchitis virus [IBV]).

The occurrence of variant IBV is a consequence of mutations and recombinations between field isolates and vaccine strains and may be heightened in regions where nonuniform massive vaccination schedules are employed. Part of the difficulty in obtaining an efficient control through vaccination is due to the occurrence of variant isolates against which there are no cross-protections (2,4,9,14,30,45,46). For the adoption of adequate control measures, the actual profiles of local isolates should be known. The molecular analysis of IBV isolates may provide the necessary information for updating vaccines and vaccination strategies (4,8,18).

The N protein is involved in mechanisms of IBV replication regulation (13,21,44), grouping virus particles, providing partial genome protection (7,9,20), and inducing T and B cell mediated immune responses (24,34,35,36). The N protein coding gene is highly conserved (12,29,39,40) even through long time spans of 30–60 yr (28,33). In addition, the N gene sequence similarity allows grouping of serologically very distinct strains into large groups (27,47).

The characterization of IBV has been performed by analysis of reverse transcription–polymerase chain reaction (RT-PCR) products through restriction fragment length polymorphism (RFLP) or sequencing, mainly of the S1 subunit spike glycoprotein (S1) protein coding gene (3,10,29). The S1 protein is involved in the induction of IBV neutralizing and serotype-specific antibodies (3,15) and shows the greatest variation among strains, as compared to the structural proteins nucleocapsid (N), transmembrane protein (M), and small hydrophobic transmembrane protein (18,26). RFLP and sequencing have been employed and are convenient methods for classifying IBV strains (10,25).

N gene conserved region primers have been designed (47) and evaluated subsequently for IBV detection (1,27). Slight differences observed on amplicons of serologically indistinguishable isolates may be useful for epidemiologic and phylogenetic studies. The analysis of the N protein coding gene might be useful for determining relationships between isolates, otherwise unnoticed by S1 analysis. It is expected that the N protein gene analysis might indicate tendencies in IBV evolution in chickens subject to strong IBV selective pressures, including specific immunity and vaccine virus recycling. The isolates were previously characterized (38) using monoclonal antibodies directed to N protein and S2 subunit spike glycoprotein conserved regions, and results showed differences among them. This paper aims to characterize 15 Brazilian IBV isolates using RFLP and sequence analysis of amplicons, in comparison to reference strains and published sequences.

MATERIALS AND METHODS

Viruses

Fifteen field isolates of IBV were recovered from natural outbreaks of IB in different types of commercial chicken flocks in Minas Gerais, Brazil (Table 1). Tissue samples were obtained from trachea, lungs, air sacs, or kidneys of nonvaccinated broiler or layer flocks between 1972 and 1989.

The La Sota strain of Newcastle disease virus (NDV) and pooled allantoic fluid (AF) of noninfected specific pathogen free (SPF) eggs were used as negative controls. Three reference strains (M41, Connecticutt-A5968 [Conn-A5968], and Arkansas-99 [Ark-99], from the American Type Culture Collection [ATCC]) were used as PCR positive controls.

Virus propagation

Isolates and reference strains were propagated for 48–72 hr into the allantoic cavity of 9–11-day-old SPF eggs (16). The allantoic fluid was collected and the virus was concentrated using 45-mm diameter dialysis tubing with 12,000 Da cutoff (Spectrapor™, Spectrum Medical Industries, Taejon, Korea) against 50% (w/v) polyvinylpyrrolidone (PVP-360, Sigma Chemical Co., St. Louis, MO) for 24–48 hr at 4 C. Concentrates were diluted at 1:100 in sterile phosphate-buffered saline, pH 7.4.

RNA extraction

Viral RNA was prepared as described previously (1) with modifications. Briefly, 15 μL of ribonucleoside vanadyl complexes (Sigma Chemical Co.) were added to 500 μL of viral concentrate. RNA extraction was performed with Trizol LS (Invitrogen, Gaithersburg, MD) and chloroform, and the nucleic acid was precipitated with isopropanol and ethanol (both from Sigma Chemical Co.) and resuspended in 20 μL 18 MΩ RNase-free water. An aliquot of 10 μL was used for immediate reverse transcription (RT).

Oligonucleotides

The primers, designated IBVN1 (reverse) and IBVN2 (forward), were previously described by Zwaagstra et al. (47) and flank a 438 base sequence on the 5′ termini of the N gene.

RT-PCR

The RT was performed with SuperScript II RNase H (Gibco BRL, Sao Paulo, Brazil) according to the manufacturer and previous reports (1,30), with modifications. The amplification was conducted starting at 94 C for 3 min, 58 C for 2 min, 72 C for 3 min, and 28 cycles of 94 C for 1 min, 64 C for 2 min, and 72 C for 3 min. The final extension was at 72 C for 10 min. The analysis of the PCR products was performed by electrophoresis on ethidium bromide-containing 1% agarose gels −0.5× TBE under ultraviolet (UV) light.

RFLP

The M41 strain was used as AvaII (Promega, Madison, WI) restriction endonuclease (RE) positive control, employed for the digestion of isolates PCR amplicons, according to the manufacturer's instructions. Digested materials were resolved by electrophoresis (2% agarose with ethidium bromide) and visualized at UV. The N gene sequence (388 bases) was mapped for the relevant restriction sites using Webcutter 2.0 (19) and compared to the published data (GenBank). To design discriminatory RFLP, the sequence of each Brazilian isolate was submitted to virtual digestion using Webcutter 2.0 with AvaII, HphI, Sau96I, and Tsp509I. Samples were then grouped according to RFLP profiles and compared to the predicted profiles.

Sequencing

The positive control strains for sequencing were M41, Ark-99, and Conn-A5968 (ATCC). From each amplicon, an 80-μL aliquot was submitted to 1.5% agarose gel electrophoresis and purification was performed with Wizard® SV gel and PCR clean-up system (Promega). After purification, the concentration of samples was estimated by agarose gel electrophoresis. The sequencing was conducted in a DNA automated sequencer (Applied Biosystems model 3700) at Embrapa (Cenargen, DF, Brasília) with ABI Prism® big dye terminator cycle sequencing ready reaction kit version 3.1 (PE Applied Biosystems Inc., Foster City, CA). Sequencing was performed on at least two amplicons of each strain or isolate, and at least three sequences were generated for each virus sample. Data were edited and observed with Chromas version 2.0 beta (Technelysium Pty. Ltd.). The consensus sequence was obtained from triplicate electrophoresis data of every isolate or strain.

Accession numbers

The GenBank nucleotide sequence accession numbers for the comparisons of obtained and published sequences were D1466, AF203006.1; D41, AY846837; Ark-99, M85244.1; ArkDPI, AY942745.1; Gray, S48137.1; Conn, AY942746.1; CU-T2, U04805.1; DE072, AF203001.1; Beaudette (M42), M28565; H52, AF352310.1; H120, AY028296.1; M41, AY851295.1; VicS, U52594.1; V5/90, U52595.1; N1/62, U52596.1; N9/74, U52597.1; N2/75, U52598.1; Q3/88, U52600.1; severe acute respiratory syndrome (SARS), AY307165.

RFLP analysis

The RFLP results were analyzed using the Treecon version 1.3b software for Windows (40).

Phylogenetic analysis

Translation frames were obtained by Sequence Utilities—6 Frame Translation software (BCM Search Launcher). Dendrograms were built by the neighbor-joining method with TREECON (40), and, to test the confidence of grouping, data were subject to bootstrap test (n = 1000). SARS (AY307165) was used as an outgroup to root the dendrogram.

RESULTS

RT-PCR

Amplified segments of 438 bp were observed for all the strains, and isolates and absent for the negative controls (Fig. 1).

RFLP, analysis, and dendrograms

The RFLP of the 438-bp amplicons resulted in the formation of three RFLP patterns for the 15 Brazilian isolates (Fig. 2). Nine Brazilian isolates (200, 208, 319, 327, 351, PM3, PM4, G, TII) showed restriction bands (approximately 240, 140, and 60 bp) similar to obtained fragments from restriction maps of the same N gene region of M41. The 140- and 60-bp bands are not shown in Fig. 2, but were weakly seen in the original photograph. Six Brazilian isolates (297, 283, 290, 29-78, PM1, and PM2) showed restriction profiles distinct of strains M41, with bands of approximately 400 and 40 bp (29-78, PM1, and PM2) and of 170 bp (297, 283, and 290). The isolates 297, 283, and 290 also showed restriction fragments distinct of all the other Brazilian isolates. The analysis of the sequencing data with WebCutter 2.0 revealed that the Brazilian isolates formed six groups (Fig. 3). Four of the Brazilian isolates (283, 290, 297, and G) were allocated together with M41, Conn-A5968, and Ark-99 (group A), although in a different branch. The Brazilian isolates obtained from clinical IB of years 1983 (283, 290, and 297; 319 and 327) or 1987 (PM1 and PM2) were grouped according to region and time period (Fig. 3). All other isolates were not grouped according to geographic area and time. Out of the nephropathogenic isolates, two were grouped together (319 and 327), but the other two (283 and 351) were grouped with the respiratory isolates (Fig. 3).

Predicted amino acid sequence and phylogenetic analysis

The dendrogram based on the predicted amino acid sequences of part of the N protein (116 amino acids) showed that all (15 of 15) of the isolates exhibited type I pattern, totally distinct of the IBV sequences available in the GenBank. A similar grouping pattern was found for Brazilian isolates as compared to the Australian isolates N9/74, N1/62, V5/90, and N2/75 (Group IV, Fig. 4).

Similarities were found in the predicted amino acid sequences among Brazilian isolates (Table 2), varying from 45% (between isolates G and 208) to 99% (PM1 and PM2) and, as compared to reference strains, varying from 42% (Q3/88 and G) to 100% (D41 and PM1). Considering the alignment of the predicted amino acid composition, a greater prevalence of basic residues was noted (data not shown). Out of the 116 analyzed amino acid residues, 18 (15%, 38%) to 24 (20%, 51%) were basic and five to nine were acid. Except for isolates 29-78 and G, 89% to 94% of basic residues were position conserved.

DISCUSSION

Fifteen Brazilian isolates were initially analyzed by RFLP. According to the RFLP analysis, the isolates were classified into six genotypes. Isolates G and TII (1975); 283, 290, and 297 (1983); 327 and 351 (1983 and 1984, respectively); PM1 and PM2 (1987); and PM3 and PM4 (1989) showed a similar AvaII RE pattern and could be grouped according to isolation year but not according to the clinical disease, probably due to N protein not being associated to pathogenicity (12). The same grouping according to isolation year was seen for isolates 283, 290, and 297 (1983); 319 and 327 (1983); and PM1 and PM2 (1987) using AvaII, HphI, Sau96I, Tsp509I. The isolates 283, 290, and 297; PM1 and PM2 were grouped together irrespective of the employed analyses (RFLP or sequencing), suggesting similarity. RFLP did not distinguish these isolates from the M41 reference strain, nor the G isolate from Conn-A5968 and Ark-99. However, the analysis of the predicted amino acid sequence did enable that discrimination. According to the analysis of the predicted amino acid sequence, a dendrogram was constructed and five groups were established. Group I was formed only by the Brazilian isolates, independently of the pathogenicity of the isolate, results which indicate that the Brazilian isolates do form an independent group and distinct of all IBV reported elsewhere (17,22,26,27,32,33). The isolates 283, 319, and 351 were obtained from natural IB in broilers with clinical nephritis and are closely grouped, as based on the predicted amino acids analysis. Although isolates allocated in group I, which caused renal disease, also caused respiratory disease, strictly respiratory isolates were observed. Several studies have demonstrated that the isolation of IBV is different and dependent on the organ sampled. The early disease is more centered in the respiratory system, from where the virus spreads to other tissues like oviduct, kidneys, intestines, and lymphoid (5,6,24). Isolates of respiratory or female reproductive system IBV were obtained from the trachea, lungs, or air sacs. Outbreaks of diarrhea and high mortality characterized by renal lesions provided the nephropathogenic isolates obtained from kidneys. The possibility exists that within the genic groups of respiratory disease nephropathogenic isolates were present, but this has not yet been experimentally verified.

In the dendrogram constructed from the predicted amino acid sequence data, a clear separation of Australian (Q3/88, V5/90, N9/74, N1/62, and N2/75) and European and U.S. isolates could be seen. Among the U.S. and European isolates, two nephropathogenic strains were observed (H52 and Gray), interspersed among the respiratory strains, suggesting the differences in N being due to different geographic origin instead of date or pathogenicity. However, it was noted that the 15 Brazilian isolates were grouped separately from Australian and the U.S. isolates, possibly indicating these being strictly Brazilian.

Despite the fact that the N protein is considered highly conserved, with a similarity greater than 80% among IBV strains (22,37,42,43,47), the data obtained show a variability of up to 55% among the Brazilian isolates and up to 58% as far as reference strains are concerned, in partial agreement with previous findings (33), which indicated 60%–63.3% of amino acid sequence identity between Australian isolates. Other authors (42) demonstrated the extremities of the N gene being less conserved.

Analyses based on the N3F10 N-specific monoclonal antibody (Mab) were previously reported (38) on the same Brazilian isolates and did not detect the PM1, PM2, PM3, 351, and 29-78 isolates, although the N3F10 antibody was not characterized according to epitope. Ignjatovic and McWatters (23) used N-specific Mab for analyzing IBV strains by enzyme-linked immunosorbent assay and Western blotting and did not detect all isolates, indicating N-based variation.

A tendency of regional IBV serotypes is reported (17,30,32,43,45), although the occurrence of several serotypes of IBV in larger countries is described.

All (15 of 15) the Brazilian IBV isolates are distinct from the previously studied IBV in Europe, United States, and Australia, including the commercial vaccine strains. In addition, the Brazilian isolates presented large genetic diversity, independently of the date of isolation, prior to and after the official adoption of vaccination in Brazil (1980), indicating the exclusive geographic and natural evolution of IBV, reinforcing the need for evaluation of local isolates to be developed as vaccine strains.

Acknowledgments

We acknowledge Dr. Guilherme Côrrea de Oliveira and Anderson Joaquim Dominitini (Centro de Pesquisas René Rachou—Minas Gerais, Brazil) for advice on E-GENE program for sequencing data quality assessment. Financial support was provided by FIP (Research Incentive Fund) from PUC Minas, FAPEMIG and CNPq.

REFERENCES

1.

A. Adzhar, K. Shaw, P. Britton, and D. Cavanagh . Universal oligonucleotides for the detection of infectious bronchitis virus by the polymerase chain reaction. Avian Pathol 25:817–836.1996.  Google Scholar

2.

M. E. Bouqdaoui, R. A. Mhand, H. Bouayoune, and M. M. Ennaji . Genetic grouping of nephropathogenic avian infectious bronchitis virus isolated in Morocco. Int. J. Poult. Sci 4:721–727.2005.  Google Scholar

3.

S. A. Callison, M. W. Jackwood, and D. A. Hilt . Molecular characterization of infectious bronchitis virus isolates foreign to the United States and comparison with United States isolates. Avian Dis 45:492–499.2001.  Google Scholar

4.

D. Cavanagh Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis virus. Avian Pathol 32:567–582.2003.  Google Scholar

5.

D. Cavanagh and S. A. Naqi . Infectious bronchitis. In: Diseases of poultry, 11th ed. Y. M. Saif, ed. Iowa State University Press, Ames, IA. pp. 101–120. 2003. Google Scholar

6.

H. Chen, A. Gill, B. K. Dove, S. R. Emmett, C. F. Kemp, M. A. Ritchie, M. Dee, and A. Hiscox . Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance. J. Virol 79:1164–1179.2005.  Google Scholar

7.

R. Cologna and B. G. Hogue . Coronavirus nucleocapsid protein-RNA interactions. Adv. Exp. Med. Biol 440:355–359.1998.  Google Scholar

8.

J. K A. Cook, S. J. Orbell, M. A. Woods, and M. B. Huggins . Breadth of protection of the respiratory tract by different live-attenuated infectious bronchitis vaccines against challenge with infectious bronchitis viruses of heterologous serotypes. Avian Pathol 28:477–485.1999.  Google Scholar

9.

E. Corse and C. E. Machamer . Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J. Virol 74:4319–4326.2000.  Google Scholar

10.

J. J. De Wit Detection of infectious bronchitis virus. Avian Pathol 29:71–93.2000.  Google Scholar

11.

G. Dhinakar Raj and R. C. Jones . Infectious bronchitis virus: immunopathogenesis of infection in the chicken. Avian Pathol 26:677–706.1997.  Google Scholar

12.

E. Falcone, E. D'Amore, L. Trani, and M. Tollis . Rapid diagnosis of avian infectious bronchitis virus by the polymerase chain reaction. J. Virol. Methods 64:125–130.1997.  Google Scholar

13.

H. Fan, A. Ooi, Y. W. Tan, S. Wang, S. Fang, D. X. Liu, and J. Lescar . The nucleocapsid protein of coronavirus infectious bronchitis virus: crystal structure of its N-terminal domain and multimerization properties. Structure 13:1859–1868.2005.  Google Scholar

14.

A. Farsang, C. Ros, L. H M. Renström, C. Baule, T. Soós, and S. Belák . Molecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain. Avian Pathol 31:229–236.2002.  Google Scholar

15.

T. M. Gallagher and M. J. Buchmeier . Coronavirus spike proteins in viral entry and pathogenesis. Virology 279:371–374.2001.  Google Scholar

16.

J. Gelb Jr. and M. W. Jackwood . Infectious bronchitis. In: Isolation and identification of avian pathogens, 4th ed. The American Association of Avian Pathologists, Kennett Square, PA. 1997. Google Scholar

17.

J. Gelb, B. S. Ladman, M. Tamayo, M. Costes, and V. Sivanandan . Novel infectious bronchitis virus S1 genotypes in Mexico 1998–1999. Avian Dis 45:1060–1063.2001.  Google Scholar

18.

J. Gelb, Y. Weisman, B. S. Ladman, and R. Meir . S1 gene characteristics and efficacy of vaccination against infectious bronchitis virus field isolates from the United States and Israel (1996 to 2000). Avian Pathol 34:194–203.2005.  Google Scholar

19.

M. Heinman Webcutter 2.0.  http://www.firstmarket.com/cutter/cut2.html. 1997. Google Scholar

20.

J. A. Hiscox, T. Wurm, L. Wilson, P. Britton, D. Cavanagh, and G. Brooks . The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus. J. Virol 75:506–512.2001.  Google Scholar

21.

K. V. Holmes and M. C. Lai . Coronaviridae: the viruses and their replication. In: Virology. 3rd ed. B. N. Fields, D. M. Knipe, and P. M. Howley eds. Lippincott-Raven Publishers, Philadelphia, PA. pp. 1075–1101. 1996. Google Scholar

22.

Y-P. Huang, H-C. Lee, M-C. Cheng, and C. H. Wang . S1 and N gene analysis of avian infectious bronchitis viruses in Taiwan. Avian Dis 48:581–589.2004.  Google Scholar

23.

J. Ignjatovic and P. G. McWatters . Monoclonal antibodies to three structural proteins of avian infectious bronchitis virus: characterization of epitopes and antigenic differentiation of Australian strains. J. Gen. Virol 72:2915–2922.1991.  Google Scholar

24.

J. Ignjatovic and S. Sapats . Identification of previously unknown antigenic epitopes on the S and N proteins of avian infectious bronchitis virus. Arch. Virol 150:91813–1831.2005.  Google Scholar

25.

M. W. Jackwood, D. A. Hilt, C-W. Lee, H. M. Kwon, S. A. Callison, K. M. Moore, H. Moscoso, H. Sellers, and S. Thayer . Data from 11 years of molecular typing infectious bronchitis virus field isolates. Avian Dis 49:614–618.2005.  Google Scholar

26.

W. Jia, K. Karaca, C. R. Parrish, and S. A. Naqi . A novel variant of avian infectious bronchitis virus resulting from recombination among three different strains. Arch. Virol 140:259–271.1995.  Google Scholar

27.

J. G. Kusters, H. G M. Niesters, J. A. Lenstra, M. C. Horzinek, and B. A. van der Zeijst . Phylogeny of antigenic variants of avian coronavirus IBV. Virology 169:217–221.1989.  Google Scholar

28.

C. W. Lee and M. W. Jackwood . Evidence of genetic diversity generated by recombination among avian coronavirus IBV. Arch. Virol 145:2135–2148.2000.  Google Scholar

29.

S. K. Lee, H. W. Sung, and H. M. Kwon . S1 glycoprotein gene analysis of infectious bronchitis viruses isolated in Korea. Arch. Virol 149:481–494.2004.  Google Scholar

30.

S. Liu and X. Kong . A new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and non-vaccinated flocks in China. Avian Pathol 33:321–327.2004.  Google Scholar

31.

P. S. Masters and L. S. Sturman . Functions of the coronavirus nucleocapsid protein. Adv. Exp. Med. Biol 276:235–238.1990.  Google Scholar

32.

R. Meir, E. Rosenblut, S. Perl, N. Kass, G. Ayali, E. Hemsani, and S. Perk . Identification of a novel nephropathogenic infectious bronchitis virus in Israel. Avian Dis 48:635–641.2004.  Google Scholar

33.

S. I. Sapats, F. Ashton, P. J. Wright, and J. Ignjatovic . Novel variation in the N protein of avian infectious bronchitis virus. Virology 226:412–417.1996.  Google Scholar

34.

J. N. Seah, L. Yu, and J. Kwang . Localization of linear B-cell epitopes on infectious bronchitis virus nucleocapsid protein. Vet. Microb 75:11–16.2000.  Google Scholar

35.

S. H. Seo and E. W. Collisson . Cytotoxic T lymphocyte responses to infectious bronchitis virus infection. Adv. Exp. Med. Biol 440:455–460.1998.  Google Scholar

36.

S. H. Seo, L. Wang, R. Smith, and E. W. Collisson . The carboxil-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. J. Virol 71:7889–7894.1997.  Google Scholar

37.

H. K. Shieh, J-H. Shien, H-Y. Chou, Y. Shimizu, J. N. Chen, and P. C. Chang . Complete nucleotide sequences of S1 and N genes of infectious bronchitis virus isolated in Japan and Taiwan. J. Vet. Med. Sci 66:555–558.2004.  Google Scholar

38.

C. M. Souza, F. R T. Rocha, N. R S. Martins, J. S. Resende, M. A. Jorge, and A. P. Rampinelli . Production of monoclonal antibodies against conserved components of infectious bronchitis virus. Arq. Bras. Med. Vet. Zootec 53:523–530.2001.  Google Scholar

39.

T. Uenaka, I. Kishimoto, S. Sato, S. Animas, S. B. Ito, T. Otsuki, and J. K. Cook . Intracloacal infection with avian infectious bronchitis virus. Avian Pathol 27:309–312.1998.  Google Scholar

40.

Y. Van de Peer and R. de Wacchter . TREECON for windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. CABIOS 10:569–570.1994.  Google Scholar

41.

C. H. Wang and C. T. Tsai . Genetic grouping for the isolates of avian infectious bronchitis virus in Taiwan. Arch. Virol 141:1677–1688.1996.  Google Scholar

42.

A. K. Williams, L. Wang, L. W. Sneed, and E. W. Collisson . Comparative analyses of the nucleocapsid genes of several strains of infectious bronchitis virus and other coronavirus. Virus Res 25:213–222.1992.  Google Scholar

43.

L. Yu, Z. Wang, Y. Jiang, S. Low, and J. Kwang . Molecular epidemiology of infectious bronchitis virus isolates from China and Southeast Asia. Avian Dis 45:201–209.2001.  Google Scholar

44.

M. Zhou, A. K. Williams, S. I. Chung, L. Wang, and E. W. Collisson . The infectious bronchitis virus nucleocapsid protein binds RNA sequences in the 3′ terminus of the genome. Virology 217:191–199.1996.  Google Scholar

45.

J-Y. Zhou, D-Y. Zhang, J-X. Ye, and L-Q. Chen . Characterization of an avian infectious bronchitis virus isolated in China from chickens with nephritis. J. Vet. Med. B 51:147–152.2004.  Google Scholar

46.

A. F. Ziegler, B. S. Ladman, P. A. Dunn, A. Schneider, S. Davison, P. G. Miller, H. Lu, D. Weinstock, M. Salem, R. J. Eckroade, and J. Gelb Jr. . Nephropathogenic infectious bronchitis in Pennsylvania chickens 1997–2000. Avian Dis 46:847–858.2002.  Google Scholar

47.

K. A. Zwaagstra, B. A M. Vander Zeijst, and J. G. Kusters . Rapid detection and identification of avian infectious bronchitis virus. J. Clin. Microbiol 30:79–84.1992.  Google Scholar

Appendices

Fig. 1. 

Agarose gel electrophoresis of RT-PCR products (part of N gene) in 1% agarose stained by ethidium bromide. Lane 1, M41; lane 2, Conn-A5968; lane 3, Ark-99; lane 4, Molecular weight marker: 100-bp DNA ladder (Promega); lane 5, 208; lane 6, 29-78; lane 7, 297; lane 8, 283; lane 9, 290; lane 10, 327; lane 11, 351; lane 12, 319; lane 13, PM1; lane 14, PM2; lane 15, PM3; lane 16, PM4; lane 17, G; lane 18, TII; lane 19, 200; lane 20, NDV (La Sota); lane 21, Negative control (AF)

i0005-2086-50-4-494-f01.gif

Fig. 2. 

RFLP patterns of the N gene of 15 IBV Brazilian isolates and reference strain (M41), digested with AvaII. Lanes 02 and 18: Molecular weight marker: 100-bp DNA ladder; lane 1, M41; lane 03, 208; lane 04, 29-78; lane 05, 297; lane 06, 283; lane 07, 290; lane 08, 327; lane 09, 351; lane 10, 319; lane 11, PM1; lane 12, PM2; lane 13, PM3; lane 14, PM4; lane 15, G; lane 16, TII; lane 17, 200

i0005-2086-50-4-494-f02.gif

Fig. 3. 

Dendrogram without root of 15 Brazilian IBV isolates, M41, Conn-A5968, and Ark-99, built with TREECON. The branch length was calculated from RFLP analysis of part of the N gene with the restriction enzymes AvaII, HphI, Sau96I, and Tsp509I. The scale represents 0.1 divergence

i0005-2086-50-4-494-f03.gif

Fig. 4. 

Dendrogram of 15 Brazilian IBV isolates, 18 IBV and SARS (out group) available in the GenBank and EMBL, as based on the predicted amino acid sequences (116 amino acids) of part of the N protein. The dendrogram was made using the neighbor-joining method with Treecon. The dendrogram is rooted to the sequence of SARS virus (accession number AY307165). Group I, PM2, PM1, 200, PM3, TII, 351, 319, 283, 290, 297, 327, 2978, G, PM4, 208 (Brazilian IBV isolates); group II (*), Q3/88 (Australian IBV isolate); group III, Vic S (Australian IBV vaccine strain), M42, M41, H120, H52 (Massachusetts), D41, D1466 (Dutch IBV strains), ArkDPI, Ark-99, Conn, Gray, DE072, CUT2 (American North IBV strains); group IV, N9/74, N1/62, V5/90, N2/75 (Australian IBV strains), group V (**), SARS. The scale represents 0.1 divergence

i0005-2086-50-4-494-f04.gif

Table 1. 

IBV isolates of infectious bronchitis outbreaks in commercial chickens (Minas Gerais, Brazil)

i0005-2086-50-4-494-t01.gif

Table 2. 

Nucleotide and predicted amino acid identity (Clustal W, EMBL software) of part of the N protein gene (388 bp) of IBV reference strains (GenBank) and Brazilian isolates

i0005-2086-50-4-494-t02.gif
Josiane T. Abreu, José S. Resende, Roberto B. Flatschart, Áurea V. Folgueras-Flatschart, Ana Cristina R. Mendes, Nelson R. S. Martins, Candice B. A. Silva, Michele C. Ferreira, and Maurício Resende "Molecular Analysis of Brazilian Infectious Bronchitis Field Isolates by Reverse Transcription–Polymerase Chain Reaction, Restriction Fragment Length Polymorphism, and Partial Sequencing of the N Gene," Avian Diseases 50(4), 494-501, (1 December 2006). https://doi.org/10.1637/7525-030706R.1
Received: 7 March 2006; Accepted: 1 June 2006; Published: 1 December 2006
JOURNAL ARTICLE
8 PAGES


SHARE
ARTICLE IMPACT
Back to Top